NCT04301063View on ClinicalTrials.gov

Assess the Effects and the Tolerance of Cosmetic Product in the Follow-up Phase of Facial Acne for 1 Year

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

May 6, 2020

Study Completion Date

May 6, 2020

Conditions

Acne Vulgaris

Interventions

OTHER

RV3278A

RV3278A is a non-rinsed cosmetic cream intended to be used every day on adolescents and young adults with acne-prone skin.

Trial Locations (8)

20124

Medical Office, Milan

27100

Medical Office, Pavia

31300

Skin Research Centre, Toulouse

75010

Centre de Santé Sabouraud - Hôpital Saint Louis, Paris

92310

cabinet Médical, Sèvres

01-817

Medical Office, Warsaw

02-625

Medical Office, Warsaw

08-818

Medical Office, Warsaw

All Listed Sponsors

lead

Pierre Fabre Dermo Cosmetique

INDUSTRY

NCT04301063 - Assess the Effects and the Tolerance of Cosmetic Product in the Follow-up Phase of Facial Acne for 1 Year | Biotech Hunter | Biotech Hunter